Aerocrine AB (LTS:0O35) Days Payable : 110.08 (As of Mar. 2015)

View and export this data going back to . Start your Free Trial

What is Aerocrine AB Days Payable?

Aerocrine AB's average Accounts Payable for the three months ended in Mar. 2015 was kr26.3 Mil. Aerocrine AB's Cost of Goods Sold for the three months ended in Mar. 2015 was kr21.8 Mil. Hence, Aerocrine AB's Days Payable for the three months ended in Mar. 2015 was 110.08.

The historical rank and industry rank for Aerocrine AB's Days Payable or its related term are showing as below:

LTS:0O35's Days Payable is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 72.99
* Ranked among companies with meaningful Days Payable only.

Aerocrine AB's Days Payable declined from Mar. 2014 (129.77) to Mar. 2015 (110.08). It may suggest that Aerocrine AB accelerated paying its suppliers.

Aerocrine AB Days Payable Historical Data

The historical data trend for Aerocrine AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aerocrine AB Days Payable Chart

Aerocrine AB Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Days Payable

Get a 7-Day Free Trial

159.59

168.30

135.52

148.32

137.45

Aerocrine AB Quarterly Data
	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15
Days Payable	Get a 7-Day Free Trial															129.77	-	-	130.71	110.08

Competitive Comparison of Aerocrine AB's Days Payable

For the Medical Devices subindustry, Aerocrine AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aerocrine AB's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aerocrine AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Aerocrine AB's Days Payable falls into.

Aerocrine AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Aerocrine AB's Days Payable for the fiscal year that ended in Dec. 2014 is calculated as

	Days Payable (A: Dec. 2014 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2013 )	+	Accounts Payable (A: Dec. 2014 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2014 )	*	Days in Period
=	( (14.987	+	26.263)	/	2 )	/	54.768	*	365
=	20.625					/	54.768	*	365
=	137.45

Aerocrine AB's Days Payable for the quarter that ended in Mar. 2015 is calculated as:

	Days Payable (Q: Mar. 2015 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2014 )	+	Accounts Payable (Q: Mar. 2015 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2015 )	*	Days in Period
=	( (26.263	+	0)	/	1 )	/	21.771	*	365 / 4
=	26.263					/	21.771	*	365 / 4
=	110.08

Aerocrine AB Days Payable Related Terms

Thank you for viewing the detailed overview of Aerocrine AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Aerocrine AB (LTS:0O35) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aerocrine AB (LTS:0O35) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.aerocrine.com

Aerocrine AB is a medical technology company focused on improving the treatment of patients with inflamed airways. The company offers exhaled nitric oxide (NO) monitoring devices for research and clinical applications. Aerocrine's devices utilize methods for measuring minute concentrations of NO, and incorporate NO scrubbers to eliminate atmospheric NO from the patient's breath. Measuring NO values helps doctors differentiate asthma from similar conditions, and differentiate various forms of asthma from other airway diseases. The company markets two products globally namely NIOX Flex and NIOX MINO. These products are widely used by primary care asthma specialists in Europe, and have recently gained US regulatory approval. Distribution agreements have also been signed in Japan, and regulatory approval has been secured in China. The company has offices and subsidiaries in Sweden, Germany, the United States, and the United Kingdom. The parent company is located in Solna, Sweden, and has sales enterprises in Sweden, Germany, the United States, and the United Kingdom. NIOX was replaced by its successor, NIOX FLEX in 2007. NIOX FLEX was the first tailor-made device for measuring exhaled nitric oxide (NO). NIOX FLEX includes enhanced data handling facilities, add-on research kits, and USB ports for communication. Moreover, a new application, NIOX Flex Flow, can determine whether lung inflammation is located centrally or more peripherally, which can be highly significant to therapy choices. The Nasal Research Kit allows measurement of nasal NO, while the FlexFlo Research Kit enables measurement of exhaled NO at variable flow rates, to help identify the location of inflammation. NIOX MINO is a compact hand-held device, marketed for smaller clinics, healthcare centers, and hospitals. NIOX MINO is intended for routine measurements of NO. Patients hold the NIOX MINO and breathe into the mouthpiece. An audible tone helps patient maintain the right flow during exhalation, whereupon results are displayed on the front of the device.

Aerocrine AB (LTS:0O35) Headlines

No Headlines